Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Preventive pharmacotherapy in type 2 diabetes mellitus.

Choudhary N, Kalra S, Unnikrishnan AG, Ajish TP.

Indian J Endocrinol Metab. 2012 Jan;16(1):33-43. doi: 10.4103/2230-8210.91183.

2.

Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639. Review.

PMID:
15846673
3.

Advances in the treatment of type 2 diabetes mellitus.

Israili ZH.

Am J Ther. 2011 Mar-Apr;18(2):117-52. doi: 10.1097/MJT.0b013e3181afbf51. Review.

PMID:
19834322
4.

Voglibose: an alpha glucosidase inhibitor.

Dabhi AS, Bhatt NR, Shah MJ.

J Clin Diagn Res. 2013 Dec;7(12):3023-7. doi: 10.7860/JCDR/2013/6373.3838. Epub 2013 Dec 15.

5.

Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.

Vos RC, van Avendonk MJ, Jansen H, Goudswaard AN, van den Donk M, Gorter K, Kerssen A, Rutten GE.

Cochrane Database Syst Rev. 2016 Sep 18;9:CD006992. [Epub ahead of print] Review.

PMID:
27640062
6.
7.

Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.

Joshi SR, Standl E, Tong N, Shah P, Kalra S, Rathod R.

Expert Opin Pharmacother. 2015;16(13):1959-81. Review.

PMID:
26255950
8.

Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.

Joshi SR, Ramachandran A, Chadha M, Chatterjee S, Rathod R, Kalra S.

Expert Opin Pharmacother. 2014 Aug;15(11):1611-20. doi: 10.1517/14656566.2014.932771. Epub 2014 Jun 25. Review.

PMID:
24963542
9.

Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.

Hariya N, Mochizuki K, Inoue S, Saito M, Fuchigami M, Goda T, Osonoi T.

Drugs R D. 2014 Sep;14(3):177-84. doi: 10.1007/s40268-014-0055-7.

10.
11.

The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.

Osonoi T, Saito M, Mochizuki K, Fukaya N, Muramatsu T, Inoue S, Fuchigami M, Goda T.

Metabolism. 2010 Dec;59(12):1816-22. doi: 10.1016/j.metabol.2010.06.006. Epub 2010 Jul 29.

PMID:
20667563
12.

Pharmacological and surgical intervention for the prevention of diabetes.

Chiasson JL.

Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:31-9; discussion 39-42. Review.

PMID:
16820729
13.

The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.

Antwi F, Fazylova N, Garcon MC, Lopez L, Rubiano R, Slyer JT.

JBI Libr Syst Rev. 2012;10(42 Suppl):1-14.

PMID:
27820152
14.

Cardiovascular manifestations of insulin resistance.

Chahwala V, Arora R.

Am J Ther. 2009 Sep-Oct;16(5):e14-28. doi: 10.1097/MJT.0b013e3180a724b3. Review.

PMID:
19114874
15.

α-Glucosidase inhibitors and their use in clinical practice.

Derosa G, Maffioli P.

Arch Med Sci. 2012 Nov 9;8(5):899-906. doi: 10.5114/aoms.2012.31621. Epub 2012 Nov 7.

16.

Impaired glucose tolerance: is there a case for pharmacologic intervention?

Costa A, Conget I, Gomis R.

Treat Endocrinol. 2002;1(4):205-10. Review.

PMID:
15799213
17.

The prevention of type 2 diabetes: what is the evidence?

Chiasson JL, Brindisi MC, Rabasa-Lhoret R.

Minerva Endocrinol. 2005 Sep;30(3):179-91. Review.

PMID:
16208307
18.

[Alpha-glucosidase inhibitor for the prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese subjects with impaired glucose tolerance].

Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K.

Nihon Rinsho. 2009 Sep;67(9):1821-5. Japanese.

PMID:
19768922
19.

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD009008.

PMID:
23633364
20.

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, De Grauw WJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005061. Review.

PMID:
17054235

Supplemental Content

Support Center